P&S-Intelligence..jpg
Benign Prostatic Hyperplasia (BPH) Therapeutics – Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments: Pharma Proff
May 09, 2019 02:56 ET | Prescient & Strategic Intelligence
NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- According to a new research report titled “Benign Prostatic Hyperplasia (BPH) Therapeutics – Pipeline Analysis 2019, Clinical Trials and Results, Patents,...
P&S-Intelligence..jpg
US Benign Prostatic Hyperplasia (BPH) Procedures to Grow at a CAGR of 4.2% by 2023: P&S Market Research
September 26, 2017 02:52 ET | P&S Market Research
NEW YORK, Sept. 26, 2017 (GLOBE NEWSWIRE) -- According to new market research report titled “US Benign Prostatic Hyperplasia (BPH) Procedures by Type (Green Light Lasers, Holmium Lasers, Thulium...